PITTSFORD, NY--(Marketwire - October 19, 2007) - Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced a presentation of animal study data on the Myotech Circulatory Support System (CSS) at the Cleveland Clinic’s 21st Century Treatment of Heart Failure Conference. The data presented indicates that the Myotech CSS holds promise to vastly improve outcomes for patients with Congestive Heart Failure (CHF).
